Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa

Journal of Infection

Volumn 40, Issue 2, 2000, Pages 164-170

  Hendry, J ^a   Butler, S ^d   Elborn, J S ^b   Govan, J R W ^d   Nelson, J ^d   Shale, D J ^c   Webb, A K ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA;

EID: 0034024782     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.1999.0626     Document Type: Article

References (28)

1. Isles A, Macluskey I, Corey M. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Paediatr. 104:1984;206-210.
2. Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia: colonisation among patients with cystic fibrosis. Am Rev Resp Dis. 131:1985;791-796.
3. Simmonds EJ, Conway SP, Ghonheim ATM, Littlewood JM. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child. 65:1990;874-877.
4. Gessner AR, Mortensen JE. Pathogenic factors of Pseudomonas cepacia isolates from patients with Cystic Fibrosis. J Med Microbiol. 33:1990;115-120.
5. Govan JRW, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 45:1996;385-407.
6. Nelson JW, Butler SL, Kreig D, Govan JRW. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol. 8:1994;89-97.
7. Stover G, Drake DR, Montie TC. Virulence of different Pseudomonas species in a burned mouse model: tissue colonisation by Pseudomonas cepacia. Infect Immun. 41:1983;1099-1144.
8. Suter S, Schaad UB, Roux-Lombard P, Girardin E, Grau G, Dayer JM. Relation between TNF-α and granulocyte elastase- a 1-proteinase inhibitor complexes in plasma of patients with cystic fibrosis. Am Rev Resp Dis. 140:1989;1640-1644.
9. Suter S, Schaad Uh, Roux L, Nydegger U, Waldvogel F. Granulocyte neutral proteases and pseudomonal elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis. 149:1984;523-531.
10. Meyer K, Lewandowski J, Zimmerman J, Nunley D, Calhoun W, Dopico G. Human neutrophil elastase a -1-antiprotease complex in cystic fibrosis. Am Rev Resp Dis. 144:1991;580-585.
11. Hughes JE, Stewart J, Barclay GR, Govan JRW. Priming of neutrophil burst activity by lipopolysaccharide of Burkholderia cepacia. Infect Immun. 65:1997;4281-4287.
12. Hutchinson ML, Poxton IR, Govan JRW. Burkholderia cepacia produces a haemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun. 66:1998;2033-2039.
13. Zughaier SM, Ryley HC, Jackson SK. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun. 67:1999;908-913.
14. Zughaier SM, Ryley HC, Jackson SK. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumour necrosis factor alpha from human monocytes. Infect Immun. 67:1999;1505-1507.
15. Aronoff SC, Quiner FJ, Stern RC. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis. Paediatr Pulmonol. 1:1991;289-293.
16. Aronoff SC, Stern RC. Serum IgG antibody to the outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis. J Infect Dis. 157:1988;934-940.
17. Lacy D, Smith A, Stableforth D, Smith G, Weller P, Brown M. Serum IgG response to B. cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with P. aeruginosa. FEMS Immunology and Medical Microbiology. 10:1995;253-262.
18. Nelson JW, Butler SL, Brown PH, Greening AP, Govan JRW. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J Med Microbiol. 39:1993;39-47.
19. Nelson JW, Govan JRW, Barclay GR. Pseudomonas aeruginosa flagellar antibodies in serum, saliva and sputum from patients with cystic fibrosis. Serodiag Immunother Inf Dis. 4:1990;351-361.
20. Brett MM, Ghonheim ATM, Littlewood JM. Serum IgG antibodies in patients with cystic fibrosis with early P. aeruginosa infection. Arch Dis Child. 62:1987;357-361.
21. Doring G, Hoiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun. 42:1983;197-201.
22. Nelson JW, Butler SL, Brown PH, Greening AP, Govan JRW. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J Med Microbiol. 39:1993;39-47.
23. Hollsing AE, Granstrom M, Vasil ML. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J Clin Microbiol. 25:1987;1830-1836.
24. Nelson JW, Barclay R, Govan JRW. Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme linked immunosorbent assay for anti pseudomonas LPS antibodies. Serodiag Immunother Infect Dis. 4:1990;9-16.
25. Moss RB. Hypergammaglobulinaemia in cystic fibrosis. Chest. 91:1987;522-526.
26. Wheeler WB, Williams M, Matthews WJ, Colten HR. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin levels: a five year longitudinal study. J Paediatr. 104:1984;695-699.
27. Tosi M, Zakem-Cloud H, Demko C. Cross-sectional and longitudinal studies of naturally occuring antibodies to Pseudomonas aeruginosa in cystic fibrosis. J Inf Dis. 172:1995;453-461.
28. Manthei U, Taussig LM, Beckerman RC, Strunk RC. Circulating immune complexes in cystic fibrosis. Am Rev Resp Dis. 126:1982;253-257.